Drug Shortage Report for PMS-RANITIDINE 300 MG
Report ID | 38878 |
Drug Identification Number | 02242454 |
Brand name | PMS-RANITIDINE 300 MG |
Common or Proper name | RANITIDINE |
Company Name | PHARMASCIENCE INC |
Market Status | DORMANT |
Active Ingredient(s) | RANITIDINE |
Strength(s) | 300MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | A02BA |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-03-26 |
Actual start date | 2018-04-02 |
Estimated end date | 2018-10-06 |
Actual end date | 2018-06-26 |
Shortage status | Resolved |
Updated date | 2018-06-29 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2018-06-29 | French | Compare |
v9 | 2018-06-29 | English | Compare |
v8 | 2018-04-03 | English | Compare |
v7 | 2018-03-23 | French | Compare |
v6 | 2018-03-23 | English | Compare |
v5 | 2018-03-19 | French | Compare |
v4 | 2018-03-19 | English | Compare |
v3 | 2018-03-06 | English | Compare |
v2 | 2018-02-06 | French | Compare |
v1 | 2018-02-06 | English | Compare |
Showing 1 to 10 of 10